A new mouse study by University of Florida Health researchers shows that multiple sclerosis can be inhibited or even reversed by using a gene therapy that stops the immune response caused by the disease in its tracks.

What is multiple sclerosis?

Multiple sclerosis (MS) is an autoimmune disease, affects around 2.3 million people worldwide and is the most common neurological disease in young adults. The average life expectancy for people with MS is around 6 to 7 years lower than the norm[1]. This lifelong condition begins when the immune system attacks the myelin sheath surrounding nerve.